市場調查報告書
商品編碼
1028259

腦監測市場:現狀分析與預測(2021年∼2027年)

Brain Monitoring Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 263 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

腦監測設備,用於神經疾病的監視和診斷。這個流程,追蹤腦功能,使用腦波計,顱內壓計,腦磁計等複數的腦監測設備。還有這些設備,也有助於監測腦內的神經活動和電力活動。神經疾病的發生率和盛行率上升,神經退化性疾病的認識高漲,創傷性腦損傷增加等,促進腦監測設備市場成長。

本報告提供全球腦監測市場調查,市場概要,各產品、病情、技術、終端用戶、地區的詳細趨勢,新型冠狀病毒感染疾病(COVID-19)的影響,收益趨勢,市場成長要素及課題,市場機會,價值鏈分析,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 簡介

  • 市場定義
  • 調查的目的
  • 限制
  • 相關利益者
  • 使用貨幣
  • 調查範圍

第2章 調查手法、前提條件

第3章 市場概要

第4章 摘要整理

第5章 COVID-19期間的腦監測市場

第6章 全球腦監測市場收益額(2019年∼2027年)

第7章 全球腦監測市場洞察:各產品

  • 設備
    • 核磁共振影像(MRI)掃描機
    • 電腦斷層攝影(CT)掃描機
    • 腦波計(EEG)設備
    • 正子放出斷層攝影(PET)掃描機
    • 睡眠監視設備
    • 腦氧濃度計
    • 肌電圖(EMG)設備
    • 顱內壓(ICP)監測器
    • 腦磁圖(MEG)設備
  • 飾品

第8章 全球腦監測市場洞察:各程序

  • 侵入性
  • 非侵入性

第9章 全球腦監測市場洞察:各技術

  • 創傷性腦損傷(TBI)
  • 中風
  • 失智症
  • 頭痛障礙
  • 睡眠障礙
  • 帕金森氏症
  • 癲癇
  • 亨丁頓舞蹈症
  • 其他

第10章 全球腦監測市場洞察:各終端用戶

  • 醫院
  • 神經內科中心
  • 門診外科中心、診療所
  • 診斷中心
  • 其他終端用戶

第11章 全球腦監測市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 其他
  • 其他地區

第12章 市場動態

  • 市場成長要素
  • 市場課題
  • 影響分析

第13章 市場機會

第14章 市場趨勢

第15章 相關法規

第16章 需求與供給方分析

  • 需求方分析
  • 供給方分析
    • 主要產品的銷售
    • 商務夥伴關係
    • 事業擴大、投資、出售
    • 合併、收購

第17章 價值鏈分析

第18章 競爭模式

  • 波特的五力分析
    • 賣主談判力
    • 買方議價能力
    • 競爭企業間的敵對關係
    • 替代品的威脅
    • 新加入業者的威脅
  • 競爭情形

第19章 企業概要

  • Nihon Kohden Corporation
  • Philips Healthcare
  • GE Healthcare
  • Siemens Healthineers
  • Compumedics, Ltd.
  • Medtronic
  • CAS Medical Systems, Inc.
  • Dragerwerk AG & Co. KGaA
  • Masimo Corporation

第20章 免責聲明

目錄
Product Code: UMHE21386

Brain monitoring devices are used to monitor and diagnose neurological conditions by exploring the structure and function of the brain. This process involves the use of several brain monitoring devices such as electroencephalography devices, intracranial pressure monitors, and magnetoencephalography to track brain functions. In addition, these devices help monitor neural and electrical activity in the brain. At present, there is an increase in the demand for electroencephalography devices among healthcare providers.

The presence of high incidence rates of diseases leading to brain disorders such as epilepsy, Alzheimer's disease, brain tumors, and multiple sclerosis will also serve this market as high impact rendering drivers. According to the estimates of the WHO in 2011 the global prevalence of epilepsy and multiple sclerosis was calculated at 50 million and 2.5 million respectively. This alarming statistic goes to show the dire need for brain monitoring devices in the global healthcare industry today. The market offers a wide range of devices to treat the abnormal brain activities and restore its functioning, depending on the case.

The growth of this market is driven owing to increasing incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases and growth in the number of traumatic brain injuries. For instance, According to WHO data, in September 2019, around 50 million people are affected by dementia globally, with nearly 10 million new cases registered each year. It is one of the major causes of disability and dependency among older people worldwide. Also, in June 2019, globally, the number of people affected with epilepsy was approximately 50 million; of this, nearly 80% live in low- and middle-income countries according to WHO data.

Based on product, the Brain Monitoring market is segmented into devices and accessories. The devices segment held the largest share of the brain monitoring market in 2019. This is mainly due to the rising incidence of neurological, neurodegenerative, psychotic, and sleep disorders, the need for early diagnosis, the availability of innovative portable and wearable home-based monitoring devices, and increasing patient awareness.

Based on disease, the brain monitoring market is segmented into traumatic brain injury (TBI), stroke, dementia, headache disorders, sleep disorders, Parkinson's disease, epilepsy, Huntington's disease, and other diseases. Traumatic brain injury (TBI) holds the largest share of the brain monitoring market by a medical condition. A major factor responsible for the large share of this market segment is the growing incidence of TBIs across the globe, leading to high demand for the management of these cases, thus requiring the intensive use of brain monitoring devices.

Depending on procedure, the market is categorized into invasive and non-invasive. The non-invasive segment is projected to show fastest growth during the forecast period, due to rise in incidences of traumatic brain injuries, high acceptance rate of minimally invasive devices, and low risk of mortality. This increases the demand for these products that propels the market growth.

Based on end-users, the global brain monitoring devices market is segmented into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end users. The hospital segment held the largest share of the global brain monitoring market in 2019. Brain monitoring is a complex process, requiring expensive and advanced devices and equipment that are mainly found in hospitals. Hospitals also see a considerably larger inflow of patients as compared to small clinics and other end users. Additionally, brain monitoring devices pose a considerable burden in terms of maintenance expenses on healthcare facilities; hospitals, more than other end-users, can bear such costs. Hence, brain monitoring devices are mostly used in hospitals, which consequently account for the largest share of this market segment.

For a better understanding of the market adoption, report provide detailed analysis for major region and countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, United Kingdom, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC), and Rest of World. North America is expected to dominate the Brain Monitoring market due to growing incidence of neurological diseases, a growing number of clinical trials of brain monitoring products, and the availability of medical reimbursement in the US. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, due to increase in number of geriatric population and rise in purchasing power of countries in the region.

Some of the major players operating in the market include Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Siemens Healthineers, Compumedics, Ltd., Medtronic, CAS Medical Systems, Dragerwerk AG & Co. KGaA and Masimo Corporation.

TABLE OF CONTENTS

1.       MARKET INTRODUCTION

  • 1.1.   Market Definitions
  • 1.2.   Objective of the Study
  • 1.3.   Limitation
  • 1.4.   Stake Holders
  • 1.5.   Currency Used in Report
  • 1.6.   Scope of the Brain Monitoring Market Study

2.       RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1.   Research Methodology for the Global Brain Monitoring Market
    • 2.1.1.Main Objective of the Global Brain Monitoring Market

3.       MARKET SYNOPSIS

4.       EXECUTIVE SUMMARY

5.       BRAIN MONITORING AMID COVID-19

6.       GLOBAL BRAIN MONITORING MARKET REVENUE (USD MN), 2019-2027F

7.       MARKET INSIGHTS BY PRODUCT

  • 7.1.   Devices
    • 7.1.1. Magnetic Resonance Imaging (MRI) Scanners
    • 7.1.2. Computerized Tomography (CT) Scanners
    • 7.1.3. Electroencephalograph (EEG) Devices
    • 7.1.4. Positron Emission Tomography (PET) Scanners
    • 7.1.5. Sleep Monitoring Devices
    • 7.1.6. Cerebral Oximeters
    • 7.1.7. Electromyography (EMG) Devices
    • 7.1.8. Intracranial Pressure (ICP) Monitors
    • 7.1.9. Magnetoencephalography (MEG) Devices
  • 7.2.    Accessories

8.       MARKET INSIGHTS BY PROCEDURE

  • 8.1.   Invasive
  • 8.2.   Non-invasive

9.       MARKET INSIGHTS BY MEDICAL CONDITION

  • 9.1.   Traumatic Brain Injury (TBI)
  • 9.2.   Stroke
  • 9.3.   Dementia
  • 9.4.   Headache Disorders
  • 9.5.   Sleep Disorders
  • 9.6.   Parkinson's Disease
  • 9.7.   Epilepsy
  • 9.8.   Huntington's Disease
  • 9.9.   Other Medical Conditions 

10.   MARKET INSIGHTS BY END-USER

  • 10.1.                     Hospitals
  • 10.2.                     Neurology Centers
  • 10.3.                     Ambulatory Surgery Centers (ASCs) & Clinics
  • 10.4.                     Diagnostic Centers
  • 10.5.                     Other End Users

11.   MARKET INSIGHTS BY REGION

  • 11.1.                     North America Brain Monitoring Market
    • 11.1.1.    United States
    • 11.1.2.    Canada
    • 11.1.3.    Rest of North America
  • 11.2.                     Europe Brain Monitoring Market
    • 11.2.1.    Germany
    • 11.2.2.    France
    • 11.2.3.    United Kingdom
    • 11.2.4.    Italy
    • 11.2.5.    Spain
    • 11.2.6.    Rest of Europe
  • 11.3.                     Asia Pacific Brain Monitoring Market
    • 11.3.1.    China
    • 11.3.2.    Japan
    • 11.3.3.    India
    • 11.3.4.    South Korea
    • 11.3.5.    Rest of Asia Pacific
  • 11.4.                     Rest of World Brain Monitoring Market

12.   BRAIN MONITORING MARKET DYNAMICS

  • 12.1.                     Market Drivers
  • 12.2.                     Market Challenges
  • 12.3.                     Impact Analysis

13.   BRAIN MONITORING MARKET OPPORTUNITIES

14.   BRAIN MONITORING MARKET TRENDS

15.   LEGAL & REGULATORY FRAMEWORK

16.   DEMAND AND SUPPLY SIDE ANALYSIS

  • 16.1.                     Demand Side Analysis
  • 16.2.                     Supply Side Analysis
    • 16.2.1.    Top Product Launches
    • 16.2.2.    Top Business Partnerships
    • 16.2.3.    Top Business Expansions, Investments and Divestitures
    • 16.2.4.    Top Merger and Acquisitions

17.   VALUE CHAIN ANALYSIS

18.   COMPETITIVE SCENARIO

  • 18.1.                     Porter's Five Forces Analysis
    • 18.1.1.    Bargaining power of Supplier
    • 18.1.2.    Bargaining power of Buyer
    • 18.1.3.    Industry Rivalry
    • 18.1.4.    Availability of Substitute
    • 18.1.5.    Threat of new Entrants
  • 18.2.                     Competitive Landscape
    • 18.2.1.    Company Shares, By Revenue

19.   COMPANY PROFILED

  • 19.1.                     Natus Medical, Inc.
  • 19.2.                     Nihon Kohden Corporation
  • 19.3.                     Philips Healthcare
  • 19.4.                     GE Healthcare
  • 19.5.                     Siemens Healthineers
  • 19.6.                     Compumedics, Ltd.
  • 19.7.                     Medtronic 
  • 19.8.                     CAS Medical Systems, Inc.
  • 19.9.                     Dragerwerk AG & Co. KGaA
  • 19.10.                  Masimo Corporation

20.   DISCLAIMER